European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthma

A Papi, DS Ferreira, I Agache, E Baraldi… - European …, 2023 - Eur Respiratory Soc
Recent clinical trials of as-needed fixed-dose combination of inhaled corticosteroid
(ICS)/formoterol have provided new evidence that may warrant a reconsideration of current …

Asthma as a risk factor for hospitalization in children with COVID‐19: a nested case‐control study

K Gaietto, MC Freeman, LA DiCicco… - Pediatric Allergy and …, 2022 - Wiley Online Library
Background Most pediatric studies of asthma and COVID‐19 to date have been ecological,
which offer limited insight. We evaluated the association between asthma and COVID‐19 at …

[HTML][HTML] Pharmacology versus convenience: a benefit/risk analysis of regular maintenance versus infrequent or as-needed inhaled corticosteroid use in mild asthma

P Daley-Yates, B Aggarwal, Z Lulic, S Fulmali… - Advances in …, 2022 - Springer
Introduction This study compared the bronchoprotective and benefit/risk profiles of various
inhaled corticosteroid (ICS) dosing regimens in mild asthma. Methods A pharmacokinetic …

2022 Year in Review: Pediatric Asthma

JA Baker - Respiratory Care, 2023 - rc.rcjournal.com
Asthma is the most common chronic disease in children. Asthma is a heterogeneous
disease characterized by variable, reversible airway obstruction and hyper-responsive …

Phenotypes and endotypes in asthma

AP McIntyre, RK Viswanathan - Precision Approaches to Heterogeneity in …, 2023 - Springer
Asthma is a broadly encompassing diagnosis of airway inflammation with significant
variability in presentation and response. Advances in molecular techniques and imaging …

Tezepelumab in the treatment of uncontrolled severe asthma

J Feist, M Lipari… - Annals of …, 2023 - journals.sagepub.com
Objective: To review the pharmacology, efficacy, and safety of subcutaneous tezepelumab in
the treatment of severe uncontrolled asthma. Data Sources: The PubMed database and …

National Asthma Education and Prevention Program 2020 guideline update: where do we go from here?

JA Krishnan, MM Cloutier, M Schatz - American Journal of …, 2021 - atsjournals.org
7. Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, et al. Treatment of
nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA …

[HTML][HTML] Systemic glucocorticoid prescriptions pattern and factors of inappropriate use in primary care institutions of Southwest China

X Luo, S Yu, Z Zeng, X Zhou, Y Liu, L Wang… - Frontiers in Public …, 2022 - frontiersin.org
Background Inappropriate use of glucocorticoids in primary care institutions is serious. It not
only causes economic burden, but leads to many adverse reactions. The purpose of this …

[HTML][HTML] Maintenance Therapy for Children and Adolescents with Asthma: Guidelines and Recommendations from the Emilia-Romagna Asthma (ERA) Study Group

V Fainardi, C Caffarelli, M Deolmi, G Zambelli… - Journal of Clinical …, 2023 - mdpi.com
Asthma is the most frequent chronic disease of childhood, affecting up to 20% of children
worldwide. The main guidelines on asthma maintenance therapy in pediatrics suggest …

Efficacy of bronchial thermoplasty in a patient panel with uncontrolled severe persistent asthma

A Zikos, M Balaan, E Hobart, S Bansal, R Saeed… - Journal of …, 2024 - Taylor & Francis
Background Bronchial thermoplasty (BT) is an approved procedure to manage uncontrolled
severe persistent asthma. Many insurance providers are reluctant to pay for BT without …